Lung cancer in the Indian subcontinent

about

Lung cancer in the Indian subcontinent

Item

http://www.wikidata.org/entity/Q28075788

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Lung cancer in the Indian subcontinent

@ast

Lung cancer in the Indian subcontinent

@en

Lung cancer in the Indian subcontinent

@nl

type

Item

label

Lung cancer in the Indian subcontinent

@ast

Lung cancer in the Indian subcontinent

@en

Lung cancer in the Indian subcontinent

@nl

prefLabel

Lung cancer in the Indian subcontinent

@ast

Lung cancer in the Indian subcontinent

@en

Lung cancer in the Indian subcontinent

@nl

P1476

Lung cancer in the Indian subcontinent

@en

P2093

Amit Joshi

http://www.w3.org/2001/XMLSchema#string

Kumar Prabhash

http://www.w3.org/2001/XMLSchema#string

Rakesh Pinninti

http://www.w3.org/2001/XMLSchema#string

Vanita Noronha

http://www.w3.org/2001/XMLSchema#string

VijayM Patil

http://www.w3.org/2001/XMLSchema#string

P2860

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

Incidence of primary lung cancer in India

Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis.

High plasma exposure to pemetrexed leads to severe hyponatremia in patients with advanced non small cell lung cancer receiving pemetrexed-platinum doublet chemotherapy.

A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)

Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study.

EGFR mutations in Indian lung cancer patients: clinical correlation and outcome to EGFR targeted therapy.

P304

95-103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4673906

http://www.w3.org/2001/XMLSchema#string

P356

10.4103/2278-330X.187571

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27606290

http://www.w3.org/2001/XMLSchema#string

P921

India

P932

4991146

http://www.w3.org/2001/XMLSchema#string